Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
- Resource Type
- article
- Source
- npj Breast Cancer, Vol 10, Iss 1, Pp 1-1 (2024)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2374-4677